ArticleCancer reports (Hoboken, N.J.)2025

Inotuzumab Ozogamicin as a Bridge to Stem Cell Transplantation in Relapsed Pediatric BCP-ALL After Tisagenlecleucel: A Case Series.

Margo Aertgeerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.